156 related articles for article (PubMed ID: 1913520)
1. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
Bast RC; Knauf S; Epenetos A; Dhokia B; Daly L; Tanner M; Soper J; Creasman W; Gall S; Knapp RC
Cancer; 1991 Oct; 68(8):1758-63. PubMed ID: 1913520
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
[TBL] [Abstract][Full Text] [Related]
3. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.
Jacobs IJ; Oram DH; Bast RC
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):396-9. PubMed ID: 1495694
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum tumor-associated antigen levels in women with pelvic masses.
Soper JT; Hunter VJ; Daly L; Tanner M; Creasman WT; Bast RC
Obstet Gynecol; 1990 Feb; 75(2):249-54. PubMed ID: 2300353
[TBL] [Abstract][Full Text] [Related]
5. CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma.
Vergote IB; Abeler VM; Børmer OP; Stigbrand T; Tropé C; Nustad K
Tumour Biol; 1992; 13(3):168-74. PubMed ID: 1626181
[TBL] [Abstract][Full Text] [Related]
6. The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary data.
Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
J Nucl Med Allied Sci; 1989; 33(1):32-6. PubMed ID: 2746365
[TBL] [Abstract][Full Text] [Related]
7. CA 125 assay used in conjunction with CA 15-3 and TAG-72 assays for discrimination between malignant and non-malignant diseases of the ovary.
Einhorn N; Knapp RC; Bast RC; Zurawski VR
Acta Oncol; 1989; 28(5):655-7. PubMed ID: 2590540
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570
[TBL] [Abstract][Full Text] [Related]
10. Independent expression in serum of three tumour-associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma.
Ward BG; Cruickshank DJ; Tucker DF; Love S
Br J Obstet Gynaecol; 1987 Jul; 94(7):696-8. PubMed ID: 2441739
[TBL] [Abstract][Full Text] [Related]
11. Placental alkaline phosphatase (PLAP)/PLAP-like alkaline phosphatase as tumour marker in relation to CA 125 and TPA for ovarian epithelial tumours.
Stigbrand T; Riklund K; Tholander B; Hirano K; Lalos O; Stendahl U
Eur J Gynaecol Oncol; 1990; 11(5):351-60. PubMed ID: 2097151
[TBL] [Abstract][Full Text] [Related]
12. The role of tumour markers in ovarian cancer.
Gargano G; Correale M; Abbate I; Falco G; De Frenza N; Lorusso V; De Lena M; De Leonardis A
Clin Exp Obstet Gynecol; 1990; 17(1):23-9. PubMed ID: 2194706
[TBL] [Abstract][Full Text] [Related]
13. Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2.
van Dam PA; Lowe DG; Watson JV; Jobling TW; Chard T; Shepherd JH
Cancer; 1991 Jul; 68(1):169-77. PubMed ID: 2049739
[TBL] [Abstract][Full Text] [Related]
14. CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinoma.
Toftager-Larsen K; Hørding U; Dreisler A; Daugaard S; Lund B; Bock J; Lundvall F; Frederiksen K; Nørgaard-Pedersen B
Gynecol Obstet Invest; 1992; 33(3):177-82. PubMed ID: 1319386
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three tumor markers--CA-125, lipid-associated sialic acid (LSA), and NB/70K--in monitoring ovarian cancer.
Petru E; Sevin BU; Averette HE; Koechli OR; Perras JP; Hilsenbeck S
Gynecol Oncol; 1990 Aug; 38(2):181-6. PubMed ID: 2387533
[TBL] [Abstract][Full Text] [Related]
16. CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers.
Ferroni P; Szpak C; Greiner JW; Simpson JF; Guadagni F; Johnston WW; Colcher D
Int J Cancer; 1990 Sep; 46(3):445-51. PubMed ID: 2394511
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
[TBL] [Abstract][Full Text] [Related]
18. Serum placental-like alkaline phosphatase (PLAP): a novel combined enzyme linked immunoassay for monitoring ovarian cancer.
Fisken J; Leonard RC; Shaw G; Bowman A; Roulston JE
J Clin Pathol; 1989 Jan; 42(1):40-5. PubMed ID: 2921344
[TBL] [Abstract][Full Text] [Related]
19. CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers.
Hørding U; Toftager-Larsen K; Dreisler A; Lund B; Daugaard S; Lundvall F; Arends J; Winkel P; Rørth M
Gynecol Obstet Invest; 1990; 30(3):178-83. PubMed ID: 2265805
[TBL] [Abstract][Full Text] [Related]
20. Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies--with special reference to the combination of PLAP and CA54/61 assay.
Nozawa S; Udagawa Y; Ohkura H; Negishi Y; Akiya K; Inaba N; Takamizawa H; Kimura E; Terashima Y
Clin Chim Acta; 1990 Jan; 186(2):275-84. PubMed ID: 2178810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
